The Helicobacter Eradication Aspirin Trial (HEAT), involving over 30,000 participants, found that a short course of antibiotics to eliminate H. pylori significantly reduces the risk of stomach bleeding for regular, low-dose aspirin users. While the treatment showed rapid, long-term protection, the benefit was found to wane after approximately 2.5 years. For more details, visit The University of Nottingham .
This is for informational purposes only. For medical advice or diagnosis, consult a professional. AI responses may include mistakes. Learn more The Helicobacter Eradication Aspirin Trial (HEAT)